We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Teva Pharmaceuticals
TEVA
$35.9B
| $1.88M | 0.02% |
30,117
-68,463
| -69% | -$3.98M |
|
|
MINI
477
DELISTED
Mobile Mini Inc
MINI
| $1.86M | 0.02% |
+43,609
| New | +$1.74M |
|
478
Darling Ingredients
DAR
$9.93B
| $1.85M | 0.02% |
132,100
| – | – |
|
479
Tronox
TROX
$995M
| $1.85M | 0.02% |
+90,808
| New | +$1.93M |
|
|
GNC
480
DELISTED
GNC Holdings, Inc.
GNC
| $1.84M | 0.02% |
37,583
+23,391
| +165% | +$1.08M |
|
481
Becton Dickinson
BDX
$43.1B
| $1.84M | 0.02% |
+13,153
| New | +$1.84M |
|
482
Equinix
EQIX
$107B
| $1.84M | 0.02% |
7,900
-12,133
| -61% | -$2.75M |
|
|
ISBC
483
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.83M | 0.02% |
+156,247
| New | +$1.77M |
|
|
JNPR
484
DELISTED
Juniper Networks
JNPR
| $1.83M | 0.02% |
81,052
-218,832
| -73% | -$5.05M |
|
|
FEIC
485
DELISTED
FEI COMPANY
FEIC
| $1.8M | 0.02% |
23,624
-20,595
| -47% | -$1.65M |
|
|
AGU
486
DELISTED
Agrium
AGU
| $1.79M | 0.02% |
+17,154
| New | +$1.83M |
|
|
XOOM
487
DELISTED
XOOM CORP COM
XOOM
| $1.79M | 0.02% |
+121,714
| New | +$1.91M |
|
488
Halliburton
HAL
$27.9B
| $1.77M | 0.02% |
40,351
-255,391
| -86% | -$10.6M |
|
489
Synaptics
SYNA
$4.41B
| $1.77M | 0.02% |
+21,720
| New | +$1.64M |
|
|
BLOX
490
DELISTED
Infoblox Inc
BLOX
| $1.76M | 0.02% |
73,892
-88,663
| -55% | -$1.91M |
|
491
Clorox
CLX
$11.6B
| $1.76M | 0.02% |
15,918
-68,724
| -81% | -$7.46M |
|
492
Outfront Media
OUT
$5.64B
| $1.74M | 0.02% |
58,920
+9,443
| +19% | +$268K |
|
|
CCXI
493
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.72M | 0.02% |
+227,658
| New | +$1.78M |
|
|
COL
494
DELISTED
Rockwell Collins
COL
| $1.71M | 0.02% |
+17,694
| New | +$1.58M |
|
|
PRA
495
DELISTED
ProAssurance
PRA
| $1.69M | 0.02% |
36,820
+13,923
| +61% | +$633K |
|
496
CarMax
KMX
$8.27B
| $1.66M | 0.02% |
+24,064
| New | +$1.57M |
|
497
Nexstar Media Group
NXST
$5.6B
| $1.65M | 0.02% |
28,865
-68,670
| -70% | -$3.64M |
|
498
Albemarle
ALB
$13.5B
| $1.63M | 0.02% |
30,764
+3,348
| +12% | +$183K |
|
499
Constellation Brands
STZ
$22.2B
| $1.61M | 0.02% |
13,870
-8,535
| -38% | -$960K |
|
|
KYTH
500
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $1.61M | 0.02% |
+32,058
| New | +$1.35M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.